234 related articles for article (PubMed ID: 36560664)
1. Inhibitory Potential of Chromene Derivatives on Structural and Non-Structural Proteins of Dengue Virus.
Dharmapalan BT; Biswas R; Sankaran S; Venkidasamy B; Thiruvengadam M; George G; Rebezov M; Zengin G; Gallo M; Montesano D; Naviglio D; Shariati MA
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560664
[TBL] [Abstract][Full Text] [Related]
2. Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study.
Khan RA; Hossain R; Siyadatpanah A; Al-Khafaji K; Khalipha ABR; Dey D; Asha UH; Biswas P; Saikat ASM; Chenari HA; Wilairatana P; Islam MT
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833913
[TBL] [Abstract][Full Text] [Related]
3. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
4. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach.
Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B
Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781
[TBL] [Abstract][Full Text] [Related]
5. Computational screening of medicinal plant phytochemicals to discover potent pan-serotype inhibitors against dengue virus.
Tahir Ul Qamar M; Maryam A; Muneer I; Xing F; Ashfaq UA; Khan FA; Anwar F; Geesi MH; Khalid RR; Rauf SA; Siddiqi AR
Sci Rep; 2019 Feb; 9(1):1433. PubMed ID: 30723263
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
Saqallah FG; Abbas MA; Wahab HA
Phytochemistry; 2022 Oct; 202():113362. PubMed ID: 35948138
[TBL] [Abstract][Full Text] [Related]
7. Construction of dengue virus protease expression plasmid and in vitro protease assay for screening antiviral inhibitors.
Lai H; Teramoto T; Padmanabhan R
Methods Mol Biol; 2014; 1138():345-60. PubMed ID: 24696347
[TBL] [Abstract][Full Text] [Related]
8. Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry.
Kuo YT; Liu CH; Li JW; Lin CJ; Jassey A; Wu HN; Perng GC; Yen MH; Lin LT
Sci Rep; 2020 Oct; 10(1):16378. PubMed ID: 33009425
[TBL] [Abstract][Full Text] [Related]
9. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
10. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
11. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
Tay MY; Fraser JE; Chan WK; Moreland NJ; Rathore AP; Wang C; Vasudevan SG; Jans DA
Antiviral Res; 2013 Sep; 99(3):301-6. PubMed ID: 23769930
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided analysis of phytochemicals as potential dengue virus inhibitors based on molecular docking, ADMET and DFT studies.
Qaddir I; Rasool N; Hussain W; Mahmood S
J Vector Borne Dis; 2017; 54(3):255-262. PubMed ID: 29097641
[TBL] [Abstract][Full Text] [Related]
13. Perspectives on the current antiviral developments towards RNA-dependent RNA polymerase (RdRp) and methyltransferase (MTase) domains of dengue virus non-structural protein 5 (DENV-NS5).
Sreekanth GP
Eur J Med Chem; 2023 Aug; 256():115416. PubMed ID: 37159959
[TBL] [Abstract][Full Text] [Related]
14. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
Purohit P; Sahoo S; Panda M; Sahoo PS; Meher BR
J Mol Model; 2022 Oct; 28(11):365. PubMed ID: 36274116
[TBL] [Abstract][Full Text] [Related]
15. An In-Silico Investigation of Phytochemicals as Antiviral Agents Against Dengue Fever.
Powers CN; Setzer WN
Comb Chem High Throughput Screen; 2016; 19(7):516-36. PubMed ID: 27151482
[TBL] [Abstract][Full Text] [Related]
16. Exploration of Carica papaya bioactive compounds as potential inhibitors of dengue NS2B, NS3 and NS5 protease.
Farooq MU; Munir B; Naeem S; Yameen M; Iqbal SZ; Ahmad A; Mustaan MA; Noor MW; Nadeem MA; Ghaffar A
Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):355-360. PubMed ID: 32122868
[TBL] [Abstract][Full Text] [Related]
17. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
18. Anthracene-based inhibitors of dengue virus NS2B-NS3 protease.
Tomlinson SM; Watowich SJ
Antiviral Res; 2011 Feb; 89(2):127-35. PubMed ID: 21185332
[TBL] [Abstract][Full Text] [Related]
19. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
Velmurugan D; Mythily U; Rao K
Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663
[TBL] [Abstract][Full Text] [Related]
20. Structure-guided Discovery of a Novel Non-peptide Inhibitor of Dengue Virus NS2B-NS3 Protease.
Li L; Basavannacharya C; Chan KW; Shang L; Vasudevan SG; Yin Z
Chem Biol Drug Des; 2015 Sep; 86(3):255-64. PubMed ID: 25533891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
